Unbound MEDLINE

The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis. Clinical endocrinology [Clin Endocrinol (Oxf)] Journal article

 
TitleThe effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis.
Author(s)Anastasilakis AD, Polyzos SA, Avramidis A, Toulis KA, Papatheodorou A, Terpos E 
InstitutionDepartment of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
SourceClin Endocrinol (Oxf) 2009 Oct 15.
AbstractSUMMARY
Objective. Parathyroid hormone increases the differentiation of osteoblast precursors through canonical wingless (Wnt) signalling, resulting in an osteoanabolic effect. We aimed to evaluate serum levels of the Wnt-inhibitor Dickkopf-1 (Dkk-1) in postmenopausal women with established osteoporosis and their changes with teriparatide (TPTD - human recombinant PTH 1-34). Design and patients. Thirty-one postmenopausal Caucasian women with established osteoporosis (mean age 66.3+/-1.4 years) received daily injections of 20 mug TPTD for 18 months. Follow-up was continued for another six months after treatment discontinuation (totally 24 months). Measurements. Serum samples for total calcium (Ca), intact PTH (iPTH), bone-specific alkaline phosphatase (BSAP), C-terminal cross-linking telopeptide of type 1 collagen (CTx) and Dkk-1 were obtained at baseline, 6 months, 18 months and 24 months after TPTD initiation. Lumbar spine bone mineral density (BMD) was measured before and after 18 months of TPTD treatment. Sixteen age- and gender-matched healthy controls were also analyzed at baseline.
Results. Serum Dkk-1 levels at baseline were significantly higher in osteoporotic women compared with controls (p<0.002). Dkk-1 increased significantly during TPTD administration (p<0.044) and decreased to baseline six months after TPTD discontinuation. Dkk-1 change was positively correlated to Ca (r=0.530, p=0.004) and negatively correlated to iPTH change (r=-0.398, p=0.040). There was no correlation between Dkk-1 and BMD changes.
Conclusions. Our data suggest that Dkk-1 levels are increased in women with postmenopausal osteoporosis. TPTD therapy results in further increase of Dkk-1 that may be compensative to TPTD-induced enhanced Wnt-signalling.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19832854
  
Advertise on this site.